Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05455424
Title Niraparib Efficacy in Patient With Unresectable Mesothelioma (NERO)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University Hospital Southampton NHS Foundation Trust
Indications

malignant mesothelioma

Therapies

Niraparib

Age Groups: senior | adult
Covered Countries


No variant requirements are available.